Carboxyl end-specific monoclonal antibodies to amyloid β protein (Aβ) subtypes (Aβ40 and Aβ42(43)) differentiate Aβ in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys

Neuroscience Letters - Tập 201 - Trang 151-154 - 1995
Shin'ichiro Nakamura1, Akira Tamaoka2, Naoya Sawamura2, Shin'ichi Shoji2, Hiroyuki Nakayama1, Fumiko Ono3, Ippei Sakakibara3, Yasuhiro Yoshikawa3, Hiroshi Mori4, Naoaki Goto5, Kunio Doi1
1Department of Veterinary Pathology, Faculty of Agriculture, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113, Japan
2Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305, Japan
3Tsukuba Primate Center for Medical Science, National Institutes of Health, Japan, 1 Hachimandai, Tsukuba, Ibaraki 305, Japan
4Department of Molecular Biology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156, Japan
5Tokyo Pathology Center, Shin-Nippon Biomedical Laboratories Ltd., 2-7-7 Shinkawa, Chuo-ku, Tokyo 104, Japan

Tài liệu tham khảo

Iwatsubo, 1994, Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43), Neuron, 13, 45, 10.1016/0896-6273(94)90458-8 Jarrett, 1993, The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease, Biochemistry, 32, 4693, 10.1021/bi00069a001 Miller, 1993, Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease, Arch. Biochem. Biophys., 301, 41, 10.1006/abbi.1993.1112 Nakamura, 1995, Histopathological studies on senile plaques and cerebral amyloidosis in cynomolgus monkeys, J. Med. Primatol. Podlisny, 1991, Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease, Am. J. Pathol., 138, 1423 Roher, 1993, Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease, J. Biol. Chem., 268, 10836, 10.1016/S0021-9258(18)53661-9 Roher, 1993, β-amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease, 90, 10836 Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 Selkoe, 1987, Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease, Science, 235, 873, 10.1126/science.3544219 Suzuki, 1994, An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants, Science, 264, 1336, 10.1126/science.8191290 Suzuki, 1994, High tissue content of soluble β 1–40 is linked to cerebral amyloid angiopathy, Am. J. Pathol., 145, 452 Tamaoka, 1992, Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels, 89, 1345 Tamaoka, 1994, Biochemical evidence for the long-tail form (Aβ1−4243) of amyloid β protein as a seed molecule in cerebral deposits of Alzheimer's disease, Biochem. Biophys. Res. Commun., 205, 834, 10.1006/bbrc.1994.2740 Tamaoka, 1994, APP missense mutation affects the ratio of amyloid β protein species (Aβ1−4243) and Aβ1–40) in familial Alzheimer's disease brain, J. Biol. Chem., 269, 32721, 10.1016/S0021-9258(20)30050-8 Tamaoka, 1995, Amyloid β protein 1−4243) (Aβ1−4243) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study, Brain Res., 679, 151, 10.1016/0006-8993(95)00162-J Wisniewski, 1973, Re-examination of the pathogenesis of the senile plaques, Vol. 2, 1